Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer
- PMID: 20018552
- PMCID: PMC2834864
- DOI: 10.1016/j.cytogfr.2009.11.005
Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer
Abstract
Transcriptional factors of the NF-kappaB family and STAT3 are ubiquitously expressed and control numerous physiological processes including development, differentiation, immunity, metabolism and cancer. Both NF-kappaB and STAT3 are rapidly activated in response to various stimuli including stresses and cytokines, although they are regulated by entirely different signaling mechanisms. Once activated, NF-kappaB and STAT3 control the expression of anti-apoptotic, pro-proliferative and immune response genes. Some of these genes overlap and require transcriptional cooperation between the two factors. The activation of and interaction between STAT3 and NF-kappaB plays a key role in controlling the dialog between the malignant cell and its microenvironment, especially with inflammatory/immune cells that infiltrate tumors. Quite often, cytokines whose expression is induced in response to NF-kappaB in immune cells of the tumor microenvironment lead to STAT3 activation in both malignant and immune cells. While within malignant and pre-malignant cells STAT3 exerts important oncogenic functions, within inflammatory cells it may also suppress tumor promotion through its anti-inflammatory effects. Other interactions and forms of crosstalk between NF-kappaB and STAT3 include physical interaction between the two, cooperation of these factors at gene promoters/enhancers, the NF-kappaB dependent expression of inhibitors of STAT3 activation and the participation of STAT3 in inflammatory cells in the negative regulation NF-kappaB. Despite these versatile and occasionally antagonistic interactions, NF-kappaB and STAT3 cooperate to promote the development and progression of colon, gastric and liver cancers. In addition to explaining the molecular pathogenesis of cancer, these interactions also offer opportunities for the design of new therapeutic interventions.
Conflict of interest statement
Authors declare no competing financial interests.
Figures
Similar articles
-
Differential expression of miRNAs regulating NF-κB and STAT3 crosstalk during colitis-associated tumorigenesis.Mol Cell Probes. 2019 Oct;47:101442. doi: 10.1016/j.mcp.2019.101442. Epub 2019 Aug 31. Mol Cell Probes. 2019. PMID: 31479716
-
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.Protein Cell. 2013 Mar;4(3):176-85. doi: 10.1007/s13238-013-2084-3. Epub 2013 Mar 13. Protein Cell. 2013. PMID: 23483479 Free PMC article. Review.
-
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.Cancer Sci. 2024 Nov;115(11):3596-3611. doi: 10.1111/cas.16317. Epub 2024 Sep 6. Cancer Sci. 2024. PMID: 39239848 Free PMC article.
-
A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-κB in tumors.Cancer Res. 2011 Jun 1;71(11):3772-80. doi: 10.1158/0008-5472.CAN-10-3304. Epub 2011 Apr 18. Cancer Res. 2011. PMID: 21502401 Free PMC article.
-
IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.EMBO Rep. 2009 Dec;10(12):1314-9. doi: 10.1038/embor.2009.243. Epub 2009 Nov 6. EMBO Rep. 2009. PMID: 19893576 Free PMC article. Review.
Cited by
-
STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.J Biol Chem. 2012 Dec 7;287(50):41667-83. doi: 10.1074/jbc.M112.390781. Epub 2012 Oct 12. J Biol Chem. 2012. PMID: 23066027 Free PMC article.
-
Phosphorylation of mammalian cytochrome c and cytochrome c oxidase in the regulation of cell destiny: respiration, apoptosis, and human disease.Adv Exp Med Biol. 2012;748:237-64. doi: 10.1007/978-1-4614-3573-0_10. Adv Exp Med Biol. 2012. PMID: 22729861 Free PMC article. Review.
-
LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway.Oncotarget. 2016 May 10;7(19):27280-94. doi: 10.18632/oncotarget.8465. Oncotarget. 2016. PMID: 27049829 Free PMC article.
-
The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.Cell Commun Signal. 2024 Jan 25;22(1):68. doi: 10.1186/s12964-023-01421-9. Cell Commun Signal. 2024. PMID: 38273295 Free PMC article. Review.
-
Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.Carcinogenesis. 2012 Nov;33(11):2208-19. doi: 10.1093/carcin/bgs213. Epub 2012 Jul 10. Carcinogenesis. 2012. PMID: 22782996 Free PMC article.
References
-
- Bishop JM. Molecular themes in oncogenesis. Cell. 1991;64:235–248. - PubMed
-
- Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell. 1999;98:295–303. - PubMed
-
- Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–436. - PubMed
-
- Karin M. NF-kB and cancer: mechanisms and targets. Mol Carcinog. 2006;45:355–361. - PubMed
-
- Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 2007;7:41–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous